AMENDMENT N°2 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENTPharmaceutical Development Agreement • November 9th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
PHARMACEUTICAL DEVELOPMENT AGREEMENT TO DEVELOP A MULTIDOSE INJECTION FOR BIM 44058*Pharmaceutical Development Agreement • September 30th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation with its principal office at Beaufour Ipsen Industrie S.A.S, rue d’Ethe Virton, 28100, France (“Ipsen”).
AMENDMENT N°1 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENTPharmaceutical Development Agreement • November 8th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
AMENDMENT N°1 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENTPharmaceutical Development Agreement • September 30th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
Exhibit 10.1 PHARMACEUTICAL DEVELOPMENT AGREEMENT This PHARMACEUTICAL DEVELOPMENT AGREEMENT (this "Development Agreement") is dated as of June 10, 2003 (the "Effective Date"), and is by and between FERRO PFANSTIEHL LABORATORIES, INC. ("Ferro...Pharmaceutical Development Agreement • September 29th, 2003 • Bioenvision Inc • Pharmaceutical preparations • Delaware
PHARMACEUTICAL DEVELOPMENT AGREEMENT TO DEVELOP A MULTIDOSE INJECTION FOR BIM 44058*Pharmaceutical Development Agreement • October 24th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation with its principal office at Beaufour Ipsen Industrie S.A.S, rue d’Ethe Virton, 28100, France (“Ipsen”).
AMENDMENT N°4 TO PHARMACEUTICAL DEVELOPMENT AGREEMENTPharmaceutical Development Agreement • December 21st, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
AMENDMENT N°3 TO PHARMACEUTICAL DEVELOPMENT AGREEMENT*Pharmaceutical Development Agreement • May 23rd, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
AMENDMENT N°3 TO PHARMACEUTICAL DEVELOPMENT AGREEMENT*Pharmaceutical Development Agreement • October 24th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
AMENDMENT N°3 TO PHARMACEUTICAL DEVELOPMENT AGREEMENT*Pharmaceutical Development Agreement • September 30th, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
AMENDMENT N°6 TO PHARMACEUTICAL DEVELOPMENT AGREEMENTPharmaceutical Development Agreement • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Joel Richard, Senior Vice-President, Peptides Development and CMC Dreux,
AMENDMENT N°1 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENTPharmaceutical Development Agreement • May 23rd, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
PHARMACEUTICAL DEVELOPMENT AGREEMENT TO DEVELOP A MULTIDOSE INJECTION FOR BIM 44058*Pharmaceutical Development Agreement • March 10th, 2015 • Radius Health, Inc. • Pharmaceutical preparations • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation with its principal office at Beaufour Ipsen Industrie S.A.S, rue d’Ethe Virton, 28100, France (“Ipsen”).
Exhibit 10.11 THIS AGREEMENT IS MADE AT PUNE ON THIS 28 DAY OF SEPTEMBER 1994. BETWEEN BIO-VED, INC. 911, Bern Court, # 110, San Jose, CA 95112 USA (hereinafter referred to as THE COMPANY) of the FIRST PART. AND DR. BHUSHAN PATWARDHAN 1471, Shukrawar...Pharmaceutical Development Agreement • December 11th, 1997 • Ayurcore Inc
Pharmaceutical Development Agreement for Medivation Dimebon Pharmaceutical DevelopmentPharmaceutical Development Agreement • March 11th, 2005 • Orion Acquisition Corp Ii • Blank checks
To verify and/or modify and qualify analytical methods for active pharmaceutical ingredient (API) and drug product, develop a 10 mg immediate release tablet that matches the current Russian tablet in dose, weight and size (Product), manufacture clinical trial material (CTM) of Product and matching Placebo, and conduct stability testing on CTM for Medivation Inc. (Client).
AMENDMENT N°2 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENTPharmaceutical Development Agreement • May 23rd, 2011 • Radius Health, Inc. • Blank checks • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Jean-Pierre Dubuc, President,
Zyber – Macoven Pharmaceuticals AgreementPharmaceutical Development Agreement • March 15th, 2010 • Pernix Therapeutics Holdings, Inc. • Real estate investment trusts • Louisiana
An agreement (“AGREEMENT”) is made this 27th day of July, 2009 by and between Zyber Pharmaceuticals, Inc. (“Zyber”), a Louisiana Corporation having an office at 208 East Bank Drive, Gonzales, Louisiana 70737 and Macoven Pharmaceuticals, LLC. (“Macoven Pharmaceuticals”), a Louisiana Limited Liability Company. Zyber and Macoven Pharmaceuticals may be collectively referred to as the “Parties.”
